Organigram Global Inc. (TSX: OGI)
Health Care · Pharmaceuticals · CA
CA$1.37
+0.74% today · -49.1% 1Y
Organigram Global Inc. (TSX: OGI) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $135.39M and employs 1,139 people.
Over the last twelve months the share price has lost 49.1%, trading between 1.20 and 3.09.
Tweenvest scores Organigram Global Inc. across four factors: quality 61/100, value 57/100, growth 100/100. Its strongest factor is growth.
OGI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $135.39M
- Revenue (TTM)
- $217.71M
- P/E
- 2.16
- EPS
- 0.64
- Dividend yield
- —
- Beta (5Y)
- 1.91
- 52-week high
- CA$3.09
- 52-week low
- CA$1.20
- Avg volume (3M)
- —
- Shares outstanding
- 141.01M
- Employees
- 1,139
- Next earnings
- —
About Organigram Global Inc.
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O’ Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company is headquartered in Toronto, Canada.
- ISIN
- CA68617J1003
- Listed since
- Jan 5, 2012
- Exchange
- The Toronto Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cuu Long Pharmaceutical Joint Stock CompanyHOSE: DCL | $137.70M | ₫48,800.00 | +4.95% |
| Kotra Industries BerhadKLSE: KOTRA | $137.58M | RM3.79 | -0.26% |
| BioSyent Inc.TSXV: RX | $135.93M | CA$17.15 | +1.39% |
| PT Kimia Farma TbkIDX: KAEF | $135.63M | Rp436.00 | +5.83% |
| Vivozon Pharmaceutical Co., Ltd.KOSDAQ: A082800 | $134.71M | ₩3,010.00 | +1.69% |
| Sinew Pharma Inc.TPEX: 6634 | $133.99M | NT$60.10 | -9.21% |
| The ACME Laboratories Ltd.DSE: ACMELAB | $133.67M | Tk77.80 | -0.51% |
| Samil Pharmaceutical Co.,LtdKOSE: A000520 | $132.73M | ₩8,350.00 | -2.91% |
Figures last refreshed Oct 11, 2026.